Busulfex

Protein Design Labs Becomes PDL BioPharma Jan 9, 2006
PR Newswire (press release), ...of hypertension when oral therapy is not feasible or desirable, Retavase(R) (reteplase) for acute myocardial infarction (AMI), and IV Busulfex(R) (busulfan), a ...

Dr. Joy L. Frestedt named Vice President of Clinical Affairs for ... Dec 13, 2005
Genetic Engineering News, ...at the Mayo Clinic in Rochester, Minnesota; Medical Information Scientist for Astra Zeneca Pharmaceuticals; and Manager of Busulfex Clinical Development for ...